Warning this is going to be a "CALM DOWN AND TRUST IN BOT"...

Warning this is going to be a "CALM DOWN AND TRUST IN BOT" post:

PAA was a good trade no doubt, even I enjoyed the ride. And it is always good to see positive attention to the small cap ASX Drug/pharma sector for many reasons... Good luck to em...

BOT should be worth 10X more than where PAA currently sits in terms of market cap. Now for this reason it is exactly why BOT presents itself as a buying opportunity currently as a Disallowed from where it sits currently... BOT with 1XFDA Approved Drug (Sofdra) and 3XPH2 Drugs Antimicrobial/ ACNE/ ROSACEA and with plenty of capital in the bank plus coverage from media/brokerage firms/instos is a much bigger affair than most things on the ASX Pharma scene.

My prediction is that on FDA formal approval in June, BOT's market cap will react/behave like NEU's ( a stock i monitored and traded a few times during its rise) or better. On approval IMO MC will hastily rise above $1billion and then keep on going up after financial performance validation/uptake in the last quarter of 2024, during this phase takeover offers may also will present to BOT board IMO., right now SP is being suppressed which is good news for all with deep pockets...or those still raising more funds to invest into BOT. I am glad to say BOT comprises of >70% of my non-trading (long termers) portfolio.

DYOR...